Outreach Research & Innovation Group

Research and Innovation Hub - Outreach Research & Innovation Group (ORIG) aim to tackle health inequality challenges in the UK. As an expert in innovation development and integrated care systems, founder Prof Andrew Wardley said "I want innovation to be at the heart of our efforts to build healthcare systems back better and stronger. To achieve this we need strong leadership from experienced clinical innovators. Clinical expertise is the point of truth that will enable the UK to unleash their vast scientific and technological potential." The proportion of people in England who survive their cancer diagnosis has been improving over time due to advances in early diagnosis and treatment. 50% of people diagnosed with cancer now survive their cancer for 10 years or more – double the percentage who survived 40 years ago. As a cancer survivor himself, Prof Andrew Wardley relates to the emotional, physical, and psychological challenges people experience when living with and beyond a life-threatening illness. Through first-hand experience, Prof Wardley relates to patient need for systemic anti-cancer therapy (SACT) drug treatment option, which increases roughly 10-15% per year, improving survival rates for cancer patients. As a National Oncology Centre, Outreach Research & Innovation Group sit between Life Science Companies and the NHS with the aim to increase the number of clinical sites across the UK providing efficiencies across time, reliability, governance and cost to deliver SACT treatments in the local communities.